Incyte Corp
Company Profile
Business description
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Contact
1801 Augustine Cut-Off
Wilmington DE 19803
USAT: +1 302 498-6700
E: mbooth@incyte.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
2,524
Incyte Corp News & Analysis
stocks
15 undervalued stocks that crushed US earnings
stocks
7 undervalued US stocks that crushed earnings
stocks
Global healthcare stocks for your watchlist
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,837.40 | 100.10 | -1.26% |
| CAC 40 | 8,088.24 | 71.59 | 0.89% |
| DAX 40 | 18,161.01 | 243.73 | 1.36% |
| Dow JONES (US) | 38,239.66 | 153.86 | 0.40% |
| FTSE 100 | 8,139.83 | 60.97 | 0.75% |
| HKSE | 17,651.15 | 366.61 | 2.12% |
| NASDAQ | 15,927.90 | 316.14 | 2.03% |
| Nikkei 225 | 37,934.76 | 306.28 | 0.81% |
| NZX 50 Index | 11,805.09 | 141.34 | -1.18% |
| S&P 500 | 5,099.96 | 51.54 | 1.02% |
| S&P/ASX 200 | 7,575.90 | 107.10 | -1.39% |
| SSE Composite Index | 3,088.64 | 35.74 | 1.17% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.03 | 0.00 | -2.94% |
| The Star Entertainment Group Ltd SGR | 0.39 | 0.01 | -2.50% |
| South32 Ltd S32 | 3.37 | 0.06 | 1.81% |
| Tietto Minerals Ltd TIE | 0.68 | 0.00 | 0.00% |
| Imugene Ltd IMU | 0.08 | 0.00 | -4.82% |
| BHP Group Ltd BHP | 43.15 | 2.08 | -4.60% |
| Jupiter Mines Ltd JMS | 0.30 | 0.01 | 1.69% |
| Red 5 Ltd RED | 0.44 | 0.01 | 2.33% |
| Telstra Group Ltd TLS | 3.64 | 0.03 | -0.82% |
| Pilbara Minerals Ltd PLS | 3.80 | 0.06 | -1.55% |